| View |
|
DRP-4362-01
|
Diclofenac diethylamine
|
Diclojack Gel
|
11.6 mg/g (equivalent to Diclofenac Sodium 10 mg/g (1% w/w)
|
Gel
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Agio Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
08 April 2028
|
| View |
|
DRP-5299-01
|
Allopurinol
|
None
|
300 mg
|
Tablet
|
Antigout
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
CLIDP Conversion
|
07 October 2024
|
10 February 2028
|
| View |
|
DRP-4029-10
|
Cefixime (as Trihydrate)
|
Cefifer-100
|
100 mg/ 5 mL
|
Granules for Suspension (Strawberry Flavor)
|
Antibacterial
|
Pharmevo (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
10 October 2024
|
12 December 2026
|
| View |
|
DRP-4936-03
|
Ketorolac Trometamol
|
Ketovex
|
30 mg / mL
|
Solution for Injection IM/IV
|
Non-Opioid Analgesic
|
Nitin Lifesciences Ltd.
|
India
|
CLIDP Conversion
|
10 October 2024
|
19 November 2028
|
| View |
|
DRP-5040-06
|
Losartan Potassium
|
None
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 October 2024
|
07 January 2029
|
| View |
|
DRP-2371-02
|
Gatifloxacin
|
None
|
3 mg/ mL
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
09 October 2024
|
03 August 2030
|
| View |
|
DRP-2748-01
|
Pioglitazone (as hydrochloride)
|
Maedglitazon
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
12 October 2024
|
31 January 2029
|
| View |
|
DRP-2748-02
|
Pioglitazone (as hydrochloride)
|
None
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
12 October 2024
|
31 January 2029
|
| View |
|
DRP-3175-08
|
Atorvastatin (as calcium)
|
VASTATOR
|
40 mg
|
Film-coated Tablet
|
Antihyperlipidemic
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
13 October 2024
|
04 January 2030
|
| View |
|
DRP-5366-01
|
Ibuprofen + Paracetamol
|
None
|
200 mg / 325 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) / Analgesic / Antipyretic
|
Brawn Laboratories Limited
|
India
|
CLIDP Conversion
|
10 October 2024
|
26 June 2029
|
| View |
|
DRP-5909-12
|
Pantoprazole (as sodium sesquihydrate)
|
Acilev
|
40mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 October 2024
|
12 January 2025
|
| View |
|
DRP-6260-04
|
Cetirizine Hydrochloride
|
AllerErase
|
10 mg
|
Tablet
|
Antihistamines (Piperazine Derivative)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 October 2024
|
03 June 2028
|
| View |
|
DRP-8392-03
|
Guaifenesin + Phenylpropanolamine HCl + Chlorphenamine Maleate + Ammonium Chloride + Sodium Citrate
|
Fermatuss
|
50mg/ 10mg/ 1mg/ 30mg/ 150mg per 5mL (cherry flavor)
|
|
Expectorant/Nasal Decongestant/Antihistamine
|
Philmed Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
10 October 2024
|
30 March 2029
|